Wanda Health Announces a New Partnership with Florida-based Smart Meter Corp

Wanda Health Inc, a leading telehealth company that provides a virtual care platform for patients with heart failure and other chronic diseases, today announced a partnership with Florida-based Smart Meter Corporation, a cellular-enabled remote monitoring devices provider, to ensure reliable, high quality data capture from patients, regardless of access to smart devices and internet connectivity.

The partnership will provide intelligent virtual care, device logistics, timely alert management and patient engagement services to complement the extensive collection of care management capabilities that comprise the Wanda Health intelligent virtual care platform.  Designed specifically for healthcare providers in North America and Europe, the partnership will give optimal data from cellular-connected devices no matter where they are located.

The growth in the digitally-connected healthcare market has exploded since the beginning of the Covid-19 pandemic, and the type of solutions and services offered by Wanda Health are seeing increased demand on all fronts. Indeed, the global connected healthcare market size is projected to grow from approximately US$51.59 billion in 2021 to approximately US$297.95 billion in 2028*, with market demand exploding across all regions, particularly in North America, Europe, Asia Pacific and elsewhere.

Wanda Health Inc is a portfolio company of EMV Capital, a wholly owned subsidiary of NetScientific PLC. Starting as a UCLA spin-out, Wanda Health’s platform warns healthcare practitioners and patients of potential adverse medical incidents, thus helping identify urgent medical care and treatment needs, and contributing to reduced re-admissions and emergency department visits. This new partnership will boost the company’s offering and provide increased service to those located in remote areas where connectivity can falter.

“Customers demand accuracy and precision in both the quality of the readings and the transmission of that data,” said Casey Pittock, Smart Meter CEO. “The combination of Smart Meter devices and the Wanda Health RPM solution will result in delivering the timely information that will improve care and facilitate billing for remote patient monitoring services.”

“Our partnership with Smart Meter will continue to enhance our intelligent virtual care platform, by increasing access to not only quality but quantity of ingested patient data,” Tom Smith, CEO of Wanda Health said. “This will help us to reach new patient populations and enhance our program offerings to healthcare providers.”

“As part of our trans-Atlantic thesis, our investment in Wanda has helped the company to focus on scaling its connected health offering in the US healthcare market, Dr Ilian Iliev, Managing Director for EMV Capital and CEO for NetScientific PLC noted.  “During COVID this market saw an explosion of demand as digitisation of healthcare services took off. We are pleased to see the results of the team’s work over the last few years, as Wanda moves towards accelerated commercialisation in the US, while exploring growth opportunities in the UK and Europe.”

*Ref: Fortune Business Insights

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version